Is Enhabit, Inc. (EHAB) Stock Outpacing Its Medical Peers This Year?

Group 1 - Enhabit (EHAB) is a notable stock in the Medical sector, currently ranked 4 in the Zacks Sector Rank, which evaluates 1003 companies across 16 sector groups [2] - The Zacks Rank system focuses on earnings estimates and revisions, with Enhabit holding a Zacks Rank of 2 (Buy), indicating a positive earnings outlook as the consensus estimate for its full-year earnings has increased by 32.1% over the past three months [3] - Year-to-date, Enhabit has returned approximately 2.8%, outperforming the Medical sector average return of -4.9% [4] Group 2 - Enhabit is part of the Medical Services industry, which includes 58 stocks and currently ranks 84 in the Zacks Industry Rank, with an average return of 0.2% this year, indicating that EHAB is performing better than its peers [5] - Another stock in the Medical sector, Doximity (DOCS), has also shown strong performance with a year-to-date return of 4.1% and a Zacks Rank of 2 (Buy) [4][5] - Investors in the Medical sector should monitor both Enhabit and Doximity for their continued solid performance [6]